Steward Partners Investment Advisory, LLC Akebia Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.72 - $2.93 $269 - $1,095	-374 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$2.26 - $3.34 $845 - $1,249	374 New	374 $1,000
Q3 2020 Oct 30, 2020	SELL	$2.39 - $13.08 $7,170 - $39,240	-3,000 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$4.1 - $10.24 $1,230 - $3,072	-300 Reduced 9.09%	3,000 $22,000
Q2 2019 Jul 25, 2019	BUY	$4.1 - $8.05 $13,529 - $26,565	3,300 New	3,300 $15,000
Q4 2018 Jan 15, 2019	SELL	$5.39 - $9.15 $4,312 - $7,320	-800 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$7.44 - $10.65 $1,190 - $1,704	-160 Reduced 16.67%	800 $7,000
Q1 2018 Apr 20, 2018	SELL	$9.53 - $15.68 $3,811 - $6,272	-400 Reduced 29.41%	960 $9,000
Q4 2017 Jan 19, 2018	BUY	$14.24 - $19.59 $19,366 - $26,642	1,360	1,360 $20,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.